Abstract
We describe an efficient cloning system utilizing adenoviral DNA-protein complexes which allows the directional cloning of genes into adenoviral expression vectors in a single step. DNA-protein complexes derived from a recombinant adenovirus (AVC2.null) were isolated by sequential use of CsCl step gradients followed by isopycnic centrifugation in a mixture of CsCl and guanidine HCl. AVC2.null is an adenoviral expression vector containing unique restriction sites between the human CMV-IE promoter and the SV40 intron/polyadenylation site. Transgenes were prepared for cloning into this vector by introduction of compatible restriction sites by PCR. A vector expressing rat granulocyte-macrophage colony-stimulating factor (GM-CSF) was constructed using DNA-protein complex as well as by traditional recombination techniques. The efficacy of our adenoviral cloning system utilizing DNA-protein complex was two logs higher than that seen using homologous recombination. All viruses generated by directional ligation of the insert into the vector DNA-protein complexes contained the desired transgene in the correct orientation. This technique greatly simplifies and accelerates the generation of recombinant adenoviral vectors.
Full Text
The Full Text of this article is available as a PDF (58.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bowers W. J., Howard D. F., Federoff H. J. Gene therapeutic strategies for neuroprotection: implications for Parkinson's disease. Exp Neurol. 1997 Mar;144(1):58–68. doi: 10.1006/exnr.1996.6389. [DOI] [PubMed] [Google Scholar]
- Brody S. L., Crystal R. G. Adenovirus-mediated in vivo gene transfer. Ann N Y Acad Sci. 1994 May 31;716:90–103. doi: 10.1111/j.1749-6632.1994.tb21705.x. [DOI] [PubMed] [Google Scholar]
- Chartier C., Degryse E., Gantzer M., Dieterle A., Pavirani A., Mehtali M. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol. 1996 Jul;70(7):4805–4810. doi: 10.1128/jvi.70.7.4805-4810.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crouzet J., Naudin L., Orsini C., Vigne E., Ferrero L., Le Roux A., Benoit P., Latta M., Torrent C., Branellec D. Recombinational construction in Escherichia coli of infectious adenoviral genomes. Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1414–1419. doi: 10.1073/pnas.94.4.1414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crystal R. G., McElvaney N. G., Rosenfeld M. A., Chu C. S., Mastrangeli A., Hay J. G., Brody S. L., Jaffe H. A., Eissa N. T., Danel C. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet. 1994 Sep;8(1):42–51. doi: 10.1038/ng0994-42. [DOI] [PubMed] [Google Scholar]
- Ertl H. C., Xiang Z. Novel vaccine approaches. J Immunol. 1996 May 15;156(10):3579–3582. [PubMed] [Google Scholar]
- Graham F. L., Prevec L. Adenovirus-based expression vectors and recombinant vaccines. Biotechnology. 1992;20:363–390. doi: 10.1016/b978-0-7506-9265-6.50022-1. [DOI] [PubMed] [Google Scholar]
- Graham F. L., Smiley J., Russell W. C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 1977 Jul;36(1):59–74. doi: 10.1099/0022-1317-36-1-59. [DOI] [PubMed] [Google Scholar]
- Gurwith M. J., Horwith G. S., Impellizzeri C. A., Davis A. R., Lubeck M. D., Hung P. P. Current use and future directions of adenovirus vaccine. Semin Respir Infect. 1989 Dec;4(4):299–303. [PubMed] [Google Scholar]
- Hardy S., Kitamura M., Harris-Stansil T., Dai Y., Phipps M. L. Construction of adenovirus vectors through Cre-lox recombination. J Virol. 1997 Mar;71(3):1842–1849. doi: 10.1128/jvi.71.3.1842-1849.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Imler J. L., Chartier C., Dieterlé A., Dreyer D., Mehtali M., Pavirani A. An efficient procedure to select and recover recombinant adenovirus vectors. Gene Ther. 1995 Jun;2(4):263–268. [PubMed] [Google Scholar]
- Jones N., Shenk T. Isolation of deletion and substitution mutants of adenovirus type 5. Cell. 1978 Jan;13(1):181–188. doi: 10.1016/0092-8674(78)90148-4. [DOI] [PubMed] [Google Scholar]
- Lozier J. N., Yankaskas J. R., Ramsey W. J., Chen L., Berschneider H., Morgan R. A. Gut epithelial cells as targets for gene therapy of hemophilia. Hum Gene Ther. 1997 Aug 10;8(12):1481–1490. doi: 10.1089/hum.1997.8.12-1481. [DOI] [PubMed] [Google Scholar]
- McGrory W. J., Bautista D. S., Graham F. L. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology. 1988 Apr;163(2):614–617. doi: 10.1016/0042-6822(88)90302-9. [DOI] [PubMed] [Google Scholar]
- Miyake S., Makimura M., Kanegae Y., Harada S., Sato Y., Takamori K., Tokuda C., Saito I. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1320–1324. doi: 10.1073/pnas.93.3.1320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robinson A. J., Younghusband H. B., Bellett A. J. A circula DNA-protein complex from adenoviruses. Virology. 1973 Nov;56(1):54–69. doi: 10.1016/0042-6822(73)90287-0. [DOI] [PubMed] [Google Scholar]
- Sharp P. A., Moore C., Haverty J. L. The infectivity of adenovirus 5 DNA-protein complex. Virology. 1976 Dec;75(2):442–456. doi: 10.1016/0042-6822(76)90042-8. [DOI] [PubMed] [Google Scholar]
- Zhang W. W., Fang X., Branch C. D., Mazur W., French B. A., Roth J. A. Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis. Biotechniques. 1993 Nov;15(5):868–872. [PubMed] [Google Scholar]